Rule 4729:9-1-04. Schedule IV controlled substances

119.03 Pursuant to section 3719.41 of the Revised Code, controlled substance schedule IV is hereby established, which schedules include the following, subject to amendment pursuant to section 3719.43 or 3719.44 of the Revised Code. (A) Narcotic drugs Unless specifically excepted by federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities set forth as follows: (1) Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit; (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2- propionoxybutane)[final dosage forms]; (3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol). (B) Depressants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Alfaxalone; (2) Alprazolam; (3) Barbital; (4) Brexanolone; (5) Bromazepam; (6) Camazepam; (7) Carisoprodol; (8) Chloral betaine; (9) Chloral hydrate; (10) Chlordiazepoxide; (11) Clobazam; (12) Clonazepam; (13) Clorazepate; (14) Clotiazepam; (15) Cloxazolam; (16) Delorazepam; (17) Diazepam; (18) Dichloralphenazone; (19) Estazolam; (20) Ethchlorvynol; (21) Ethinamate; (22) Ethyl loflazepate; (23) Fludiazepam; (24) Flunitrazepam; (25) Flurazepam; (26) Fospropofol; (27) Halazepam; (28) Haloxazolam; (29) Ketazolam; (30) Loprazolam; (31) Lorazepam; (32) Lormetazepam; (33) Mebutamate; (34) Medazepam; (35) Meprobamate; (36) Methohexital; (37) Methylphenobarbital (mephobarbital); (38) Midaz

(18) Dichloralphenazone; (19) Estazolam; (20) Ethchlorvynol; (21) Ethinamate; (22) Ethyl loflazepate; (23) Fludiazepam; (24) Flunitrazepam; (25) Flurazepam; (26) Fospropofol; (27) Halazepam; (28) Haloxazolam; (29) Ketazolam; (30) Loprazolam; (31) Lorazepam; (32) Lormetazepam; (33) Mebutamate; (34) Medazepam; (35) Meprobamate; (36) Methohexital; (37) Methylphenobarbital (mephobarbital); (38) Midazolam; (39) Nimetazepam; (40) Nitrazepam; (41) Nordiazepam; (42) Oxazepam; (43) Oxazolam; (44) Paraldehyde; (45) Petrichloral; (46) Phenobarbital; (47) Pinazepam; (48) Prazepam; (49) Quazepam; (50) Suvorexant; (51) Temazepam; (52) Tetrazepam; (53) Triazolam; (54) Zaleplon; (55) Zolpidem; (56) Zopiclone. (C) Lorcaserin Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible: Lorcaserin. (D) Stimulants Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, their optical isomers, position isomers, or geometric isomers, and salts of these isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Mazindol; (6) Mefenorex; (7) Modafinil; (8) Pemoline (including organometallic complexes and chelates thereof); (9) Phentermine; (10) Pipradrol; (11) Sibutramine; (12) Solriamfetol (2-amino-3-phenylpropyl car-bamate; benzenepropanol, beta-amino-, carbamate (ester)); (13) SPA [(-)-1-dimethylamino-1,2-diphenylethane]

((+)-norpseudoephedrine); (2) Diethylpropion; (3) Fencamfamin; (4) Fenproporex; (5) Mazindol; (6) Mefenorex; (7) Modafinil; (8) Pemoline (including organometallic complexes and chelates thereof); (9) Phentermine; (10) Pipradrol; (11) Sibutramine; (12) Solriamfetol (2-amino-3-phenylpropyl car-bamate; benzenepropanol, beta-amino-, carbamate (ester)); (13) SPA [(-)-1-dimethylamino-1,2-diphenylethane]. (E) Other substances Unless specifically excepted under federal drug abuse control laws or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including their salts: (1) Pentazocine; (2) Butorphanol (including its optical isomers); (3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1- (4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers. Last updated September 6, 2024 at 8:19 AM Supplemental Information Authorized By: 4729.26 , 3719.28 , 3719.41 Amplifies: 3719.43 , 3719.44 8/6/2029 9/1/2014